Brooktree Capital Management »

Amgen shares owned by Brooktree Capital Management

Quarter-by-quarter ownership of Amgen (AMGN) shares owned by Brooktree Capital Management from 13F filings

Historical chart of Brooktree Capital Management investment in Amgen

Tip: Access up to 7 years of quarterly data

All positions including Amgen held by Brooktree Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amgen by Brooktree Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $282k 1.0k 282.20
2025-06-30 $279k 1.0k 279.21